Y-Intercept (HK)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-476,488
Closed -$2.85M 2041
2026
Q1
$2.85M Buy
476,488
+70,326
+17% +$529K 0.05% 552
2025
Q4
$2.91M Buy
406,162
+218,909
+117% +$1.73M 0.07% 439
2025
Q3
$2M Buy
+187,253
New +$1.84M 0.05% 604
2024
Q2
Sell
-37,985
Closed -$714K 1771
2024
Q1
$714K Buy
+37,985
New +$652K 0.05% 529
2023
Q4
Sell
-25,899
Closed -$450K 1535
2023
Q3
$450K Buy
+25,899
New +$540K 0.04% 604
2023
Q1
Sell
-13,537
Closed -$378K 1435
2022
Q4
$378K Buy
+13,537
New +$346K 0.06% 547
2022
Q2
Sell
-5,853
Closed -$204K 1098
2022
Q1
$204K Buy
+5,853
New +$200K 0.05% 614

Other funds holding OGN

Y-Intercept (HK)'s OGN Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 476,488 shares — an estimated $2.85M sold.

Y-Intercept (HK) first reported a position in OGN in Q1 2022 and held it in 7 quarters. The position peaked at $2.91M in Q4 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 476,488 Organon & Co shares in Q2 2026, an estimated $2.85M.
  • Y-Intercept (HK) first reported a position in Organon & Co in Q1 2022 and held it in 7 quarters.
  • Y-Intercept (HK)'s Organon & Co position peaked at $2.91M in Q4 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.